A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD8329 After Administration of Multiple Ascending Doses in Abdominally Obese But Otherwise Healthy Male Subjects.

Trial Profile

A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD8329 After Administration of Multiple Ascending Doses in Abdominally Obese But Otherwise Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 May 2011

At a glance

  • Drugs AZD 8329 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Most Recent Events

    • 09 May 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 09 May 2011 Status changed from suspended to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Actual initiation date changed from Oct 2010 to Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top